TCHL - a phase II neo-adjuvant study assessing TCH (docetaxel, carboplatin and trastuzumab) and TCHL (docetaxel, carboplatin, trastuzumab and lapatinib) in HER-2 positive breast cancer patients: a 5-year follow-up with serum biomarker analysis
TCHL——一项评估TCH(多西他赛、卡铂和曲妥珠单抗)和TCHL(多西他赛、卡铂、曲妥珠单抗和拉帕替尼)方案在HER-2阳性乳腺癌患者中疗效的II期新辅助治疗研究:一项为期5年的随访研究及血清生物标志物分析
期刊:Acta Oncologica
影响因子:2.2
doi:10.2340/1651-226X.2025.43143
Crown, John; Eustace, Alex J; Collins, Denis M; Keane, Maccon; Coate, Linda; Kennedy, John; O'Reilly, Seamus; Kelly, Catherine; O'Connor, Miriam; Martin, Michael; Murphy, Conleth; Duffy, Karen; Walshe, Janice; Gullo, Giuseppe; Mahgoub, Thamir; Alvarez-Iglesias, Alberto; Parker, Imelda; Donachie, Vicky; Teiserskiene, Ausra; Madden, Stephen F; Moulton, Brian; O'Donovan, Norma; Hennessy, Bryan T